FDA 483 - Batzofin Fertility Services d.b.a. New York Fertility Services - April 29, 2019
Batzofin Fertility Services d.b.a. New York Fertility Services in New York received a Form 483 with four observations related to inadequate donor screening and eligibility determination for human cells, tissues, and cellular and tissue-based products (HCT/Ps). The firm failed to properly screen donors for communicable disease risks, including Zika virus, and did not have adequately defined and documented procedures for donor eligibility. Additionally, some donors with risk factors were deemed eligible, and specimens for testing were not collected at appropriate times.
- Inspection date
- April 29, 2019
- Product type
- biologics
ID · 1bd232e3-4f3e-4654-86fa-b4e29879e94b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.